BMY logo

Bristol-Myers Squibb (BMY) Cash From Investing

Annual CFI

-$2.29 B
-$1.23 B-116.10%

December 31, 2023


Summary


Performance

BMY Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBMYcash flowmetrics:

Quarterly CFI

-$219.00 M
+$1.10 B+83.40%

September 30, 2024


Summary


Performance

BMY Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBMYcash flowmetrics:

TTM CFI

-$22.50 B
+$191.00 M+0.84%

September 30, 2024


Summary


Performance

BMY TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBMYcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BMY Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-116.1%+83.7%-880.5%
3 y3 years+78.9%+83.7%-880.5%
5 y5 years-14.8%+83.7%-880.5%

BMY Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-326.6%at low-118.0%+98.9%-8623.5%+0.8%
5 y5-year-326.6%+78.9%-118.0%+98.9%-8623.5%+0.8%
alltimeall time-145.2%+78.9%-105.6%+98.9%-543.0%+0.8%

Bristol-Myers Squibb Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$219.00 M(-83.4%)
-$22.50 B(-0.8%)
Jun 2024
-
-$1.32 B(-93.3%)
-$22.69 B(+4.6%)
Mar 2024
-
-$19.62 B(+1357.5%)
-$21.70 B(+845.7%)
Dec 2023
-$2.29 B(+116.1%)
-$1.35 B(+228.3%)
-$2.29 B(-969.3%)
Sep 2023
-
-$410.00 M(+24.6%)
$264.00 M(-118.8%)
Jun 2023
-
-$329.00 M(+56.7%)
-$1.41 B(+2.9%)
Mar 2023
-
-$210.00 M(-117.3%)
-$1.37 B(+28.7%)
Dec 2022
-$1.06 B(+97.4%)
$1.21 B(-158.3%)
-$1.06 B(-43.3%)
Sep 2022
-
-$2.08 B(+620.1%)
-$1.87 B(+143.7%)
Jun 2022
-
-$289.00 M(-404.2%)
-$769.00 M(+156.3%)
Mar 2022
-
$95.00 M(-76.3%)
-$300.00 M(-44.2%)
Dec 2021
-$538.00 M(-95.0%)
$401.00 M(-141.1%)
-$538.00 M(-95.8%)
Sep 2021
-
-$976.00 M(-642.2%)
-$12.75 B(+6.4%)
Jun 2021
-
$180.00 M(-225.9%)
-$11.99 B(+3.2%)
Mar 2021
-
-$143.00 M(-98.8%)
-$11.61 B(+6.9%)
Dec 2020
-$10.86 B(+9.5%)
-$11.81 B(+5445.5%)
-$10.86 B(-3.3%)
Sep 2020
-
-$213.00 M(-138.3%)
-$11.23 B(+6.7%)
Jun 2020
-
$556.00 M(-8.9%)
-$10.52 B(+1.5%)
Mar 2020
-
$610.00 M(-105.0%)
-$10.36 B(+4.5%)
Dec 2019
-$9.91 B(+395.7%)
-$12.18 B(-2580.4%)
-$9.91 B(-1333.0%)
Sep 2019
-
$491.00 M(-31.3%)
$804.00 M(+384.3%)
Jun 2019
-
$715.00 M(-32.5%)
$166.00 M(-118.5%)
Mar 2019
-
$1.06 B(-172.5%)
-$897.00 M(-55.1%)
Dec 2018
-$2.00 B(+2930.3%)
-$1.46 B(+894.6%)
-$2.00 B(-515.8%)
Sep 2018
-
-$147.00 M(-57.8%)
$481.00 M(-37.5%)
Jun 2018
-
-$348.00 M(+709.3%)
$770.00 M(+719.1%)
Mar 2018
-
-$43.00 M(-104.2%)
$94.00 M(-242.4%)
Dec 2017
-$66.00 M(-104.5%)
$1.02 B(+617.6%)
-$66.00 M(-93.8%)
Sep 2017
-
$142.00 M(-113.9%)
-$1.07 B(-32.3%)
Jun 2017
-
-$1.02 B(+404.4%)
-$1.58 B(+959.7%)
Mar 2017
-
-$203.00 M(-1368.8%)
-$149.00 M(-110.1%)
Dec 2016
$1.48 B(-194.1%)
$16.00 M(-104.3%)
$1.48 B(+208.3%)
Sep 2016
-
-$368.00 M(-190.6%)
$480.00 M(-38.9%)
Jun 2016
-
$406.00 M(-71.5%)
$786.00 M(-187.3%)
Mar 2016
-
$1.43 B(-244.9%)
-$900.00 M(-42.7%)
Dec 2015
-$1.57 B(-229.3%)
-$984.00 M(+1487.1%)
-$1.57 B(+563.3%)
Sep 2015
-
-$62.00 M(-95.2%)
-$237.00 M(+2054.5%)
Jun 2015
-
-$1.28 B(-269.8%)
-$11.00 M(-95.5%)
Mar 2015
-
$754.00 M(+114.8%)
-$242.00 M(-119.9%)
Dec 2014
$1.22 B(-312.6%)
$351.00 M(+114.0%)
$1.22 B(+121.1%)
Sep 2014
-
$164.00 M(-110.9%)
$550.00 M(-718.0%)
Jun 2014
-
-$1.51 B(-168.3%)
-$89.00 M(-106.0%)
Mar 2014
-
$2.21 B(-802.2%)
$1.48 B(-358.6%)
Dec 2013
-$572.00 M(-91.5%)
-$315.00 M(-33.7%)
-$572.00 M(-2960.0%)
Sep 2013
-
-$475.00 M(-933.3%)
$20.00 M(-100.5%)
Jun 2013
-
$57.00 M(-64.6%)
-$3.71 B(+4.8%)
Mar 2013
-
$161.00 M(-41.9%)
-$3.54 B(-47.4%)
Dec 2012
-$6.73 B(+368.1%)
$277.00 M(-106.6%)
-$6.73 B(+3.3%)
Sep 2012
-
-$4.20 B(-1959.7%)
-$6.51 B(+163.6%)
Jun 2012
-
$226.00 M(-107.5%)
-$2.47 B(-18.4%)
Mar 2012
-
-$3.03 B(-711.5%)
-$3.03 B(+110.6%)
Dec 2011
-$1.44 B(-62.3%)
$495.00 M(-403.7%)
-$1.44 B(-67.4%)
Sep 2011
-
-$163.00 M(-50.9%)
-$4.41 B(+33.7%)
Jun 2011
-
-$332.00 M(-76.9%)
-$3.30 B(+20.9%)
Mar 2011
-
-$1.44 B(-42.0%)
-$2.73 B(-28.4%)
Dec 2010
-$3.81 B(-13.0%)
-$2.48 B(-361.5%)
-$3.81 B(+61.5%)
Sep 2010
-
$948.00 M(+298.3%)
-$2.36 B(-55.4%)
Jun 2010
-
$238.00 M(-109.4%)
-$5.30 B(-11.3%)
Mar 2010
-
-$2.52 B(+145.3%)
-$5.97 B(+36.4%)
Dec 2009
-$4.38 B(-186.2%)
-$1.03 B(-48.4%)
-$4.38 B(+92.2%)
Sep 2009
-
-$1.99 B(+354.1%)
-$2.28 B(-163.0%)
Jun 2009
-
-$438.00 M(-52.7%)
$3.62 B(+1.2%)
Mar 2009
-
-$926.00 M(-186.2%)
$3.58 B(-29.6%)
Dec 2008
$5.08 B(-2614.4%)
$1.07 B(-72.5%)
$5.08 B(+25.7%)
Sep 2008
-
$3.91 B(-912.9%)
$4.04 B(+672.3%)
Jun 2008
-
-$481.00 M(-183.5%)
$523.00 M(+42.5%)
Mar 2008
-
$576.00 M(+1594.1%)
$367.00 M(-281.7%)
Dec 2007
-$202.00 M
$34.00 M(-91.4%)
-$202.00 M(-140.1%)
Sep 2007
-
$394.00 M(-161.9%)
$504.00 M(<-9900.0%)
Jun 2007
-
-$637.00 M(-9200.0%)
-$2.00 M(-100.4%)
DateAnnualQuarterlyTTM
Mar 2007
-
$7.00 M(-99.1%)
$490.00 M(+137.9%)
Dec 2006
$206.00 M(-82.7%)
$740.00 M(-760.7%)
$206.00 M(-111.1%)
Sep 2006
-
-$112.00 M(-22.8%)
-$1.86 B(+11.7%)
Jun 2006
-
-$145.00 M(-47.7%)
-$1.66 B(>+9900.0%)
Mar 2006
-
-$277.00 M(-79.1%)
-$15.00 M(-101.3%)
Dec 2005
$1.19 B(-173.4%)
-$1.32 B(-1713.4%)
$1.19 B(-50.4%)
Sep 2005
-
$82.00 M(-94.5%)
$2.40 B(+30.6%)
Jun 2005
-
$1.50 B(+61.8%)
$1.84 B(-2143.3%)
Mar 2005
-
$929.00 M(-922.1%)
-$90.00 M(-94.5%)
Dec 2004
-$1.62 B(-32.9%)
-$113.00 M(-76.5%)
-$1.62 B(-34.9%)
Sep 2004
-
-$480.00 M(+12.7%)
-$2.49 B(-1.6%)
Jun 2004
-
-$426.00 M(-29.4%)
-$2.53 B(+5.5%)
Mar 2004
-
-$603.00 M(-38.7%)
-$2.40 B(-0.7%)
Dec 2003
-$2.42 B(+19.2%)
-$984.00 M(+88.9%)
-$2.42 B(-0.1%)
Sep 2003
-
-$521.00 M(+77.2%)
-$2.42 B(+8.8%)
Jun 2003
-
-$294.00 M(-52.6%)
-$2.23 B(+8.0%)
Mar 2003
-
-$620.00 M(-37.1%)
-$2.06 B(+1.5%)
Dec 2002
-$2.03 B(-58.3%)
-$986.00 M(+202.5%)
-$2.03 B(-200.1%)
Sep 2002
-
-$326.00 M(+152.7%)
$2.03 B(-139.3%)
Jun 2002
-
-$129.00 M(-78.1%)
-$5.16 B(+0.3%)
Mar 2002
-
-$589.00 M(-119.2%)
-$5.14 B(+5.7%)
Dec 2001
-$4.86 B(<-9900.0%)
$3.07 B(-140.9%)
-$4.86 B(-41.2%)
Sep 2001
-
-$7.51 B(+6669.4%)
-$8.27 B(+1917.1%)
Jun 2001
-
-$111.00 M(-64.2%)
-$410.00 M(+2.8%)
Mar 2001
-
-$310.00 M(-7.5%)
-$399.00 M(-2593.8%)
Dec 2000
$16.00 M(-102.1%)
-$335.00 M(-196.8%)
$16.00 M(+166.7%)
Sep 2000
-
$346.00 M(-446.0%)
$6.00 M(-101.4%)
Jun 2000
-
-$100.00 M(-195.2%)
-$415.00 M(-18.3%)
Mar 2000
-
$105.00 M(-130.4%)
-$508.00 M(-33.1%)
Dec 1999
-$759.00 M(+119.4%)
-$345.00 M(+360.0%)
-$759.00 M(+24.6%)
Sep 1999
-
-$75.00 M(-61.1%)
-$609.00 M(-13.6%)
Jun 1999
-
-$193.00 M(+32.2%)
-$705.00 M(+31.0%)
Mar 1999
-
-$146.00 M(-25.1%)
-$538.00 M(+55.5%)
Dec 1998
-$346.00 M(-35.0%)
-$195.00 M(+14.0%)
-$346.00 M(+15.3%)
Sep 1998
-
-$171.00 M(+557.7%)
-$300.00 M(-10.7%)
Jun 1998
-
-$26.00 M(-156.5%)
-$336.00 M(-4.3%)
Mar 1998
-
$46.00 M(-130.9%)
-$351.00 M(-34.0%)
Dec 1997
-$532.00 M(-25.8%)
-$149.00 M(-28.0%)
-$532.00 M(+18.5%)
Sep 1997
-
-$207.00 M(+404.9%)
-$449.00 M(+27.6%)
Jun 1997
-
-$41.00 M(-69.6%)
-$352.00 M(-34.9%)
Mar 1997
-
-$135.00 M(+104.5%)
-$541.00 M(-24.5%)
Dec 1996
-$717.00 M(+13.6%)
-$66.00 M(-40.0%)
-$717.00 M(-14.2%)
Sep 1996
-
-$110.00 M(-52.2%)
-$836.00 M(-4.3%)
Jun 1996
-
-$230.00 M(-26.0%)
-$874.00 M(+29.5%)
Mar 1996
-
-$311.00 M(+68.1%)
-$675.00 M(+7.0%)
Dec 1995
-$631.00 M(-55.7%)
-$185.00 M(+25.0%)
-$631.00 M(-9.6%)
Sep 1995
-
-$148.00 M(+377.4%)
-$698.00 M(-50.5%)
Jun 1995
-
-$31.00 M(-88.4%)
-$1.41 B(-9.6%)
Mar 1995
-
-$267.00 M(+6.0%)
-$1.56 B(+9.6%)
Dec 1994
-$1.42 B(+138.5%)
-$252.00 M(-70.7%)
-$1.42 B(+8.1%)
Sep 1994
-
-$861.00 M(+378.3%)
-$1.32 B(+153.8%)
Jun 1994
-
-$180.00 M(+37.4%)
-$519.00 M(+92.2%)
Mar 1994
-
-$131.00 M(-9.7%)
-$270.00 M(-54.8%)
Dec 1993
-$597.00 M(-238.8%)
-$145.00 M(+130.2%)
-$597.00 M(-223.1%)
Sep 1993
-
-$63.00 M(-191.3%)
$485.00 M(+37.8%)
Jun 1993
-
$69.00 M(-115.1%)
$352.00 M(+295.5%)
Mar 1993
-
-$458.00 M(-148.9%)
$89.00 M(-79.3%)
Dec 1992
$430.00 M(-24.7%)
$937.00 M(-578.1%)
$430.00 M(-169.8%)
Sep 1992
-
-$196.00 M(+1.0%)
-$616.00 M(+56.7%)
Jun 1992
-
-$194.00 M(+65.8%)
-$393.00 M(-235.5%)
Mar 1992
-
-$117.00 M(+7.3%)
$290.00 M(-49.2%)
Dec 1991
$571.00 M(-448.2%)
-$109.00 M(-503.7%)
$571.00 M(-1602.6%)
Sep 1991
-
$27.00 M(-94.5%)
-$38.00 M(-60.8%)
Jun 1991
-
$489.00 M(+198.2%)
-$97.00 M(-72.4%)
Mar 1991
-
$164.00 M(-122.8%)
-$352.00 M(+114.6%)
Dec 1990
-$164.00 M(-89.9%)
-$718.00 M(+2143.8%)
-$164.00 M(-129.6%)
Sep 1990
-
-$32.00 M(-113.7%)
$554.00 M(-5.5%)
Jun 1990
-
$234.00 M(-33.5%)
$586.00 M(+66.5%)
Mar 1990
-
$352.00 M
$352.00 M
Dec 1989
-$1.63 B
-
-

FAQ

  • What is Bristol-Myers Squibb annual cash flow from investing activities?
  • What is the all time high annual CFI for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual CFI year-on-year change?
  • What is Bristol-Myers Squibb quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly CFI year-on-year change?
  • What is Bristol-Myers Squibb TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb TTM CFI year-on-year change?

What is Bristol-Myers Squibb annual cash flow from investing activities?

The current annual CFI of BMY is -$2.29 B

What is the all time high annual CFI for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual cash flow from investing activities is $5.08 B

What is Bristol-Myers Squibb annual CFI year-on-year change?

Over the past year, BMY annual cash flow from investing activities has changed by -$1.23 B (-116.10%)

What is Bristol-Myers Squibb quarterly cash flow from investing activities?

The current quarterly CFI of BMY is -$219.00 M

What is the all time high quarterly CFI for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly cash flow from investing activities is $3.91 B

What is Bristol-Myers Squibb quarterly CFI year-on-year change?

Over the past year, BMY quarterly cash flow from investing activities has changed by +$1.13 B (+83.73%)

What is Bristol-Myers Squibb TTM cash flow from investing activities?

The current TTM CFI of BMY is -$22.50 B

What is the all time high TTM CFI for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high TTM cash flow from investing activities is $5.08 B

What is Bristol-Myers Squibb TTM CFI year-on-year change?

Over the past year, BMY TTM cash flow from investing activities has changed by -$20.21 B (-880.48%)